Cheniere Energy vs McKesson Corporation — how do they compare? Cheniere Energy trades at $278.18 (market cap $57.39B), while McKesson Corporation trades at $938.84 (market cap $108.46B). The key difference: McKesson Corporation is the larger of the two by market cap, and Cheniere Energy pays the higher dividend (0.8%). Which is the better fit depends on your goals — on Pluang, investors hold Cheniere Energy for 10 Days and McKesson Corporation for 74 Days on average.
| LNG | MCK | |
|---|---|---|
Market Cap | $57.39B | $108.46B |
Volume | 1,215,835 | 712,607 |
Sector | Energy | Health |
52-Week High | $296.91 | $995.69 |
52-Week Low | $188.83 | $725.17 |
Typical Hold Time | 10 Days | 74 Days |
Enterprise Value | $82.85B | $115.00B |
Dividend Yield | 0.8% | 0.4% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McKesson Corporation (MCK) trades at $930.25, up 2.19% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent news highlights the extension of McKesson's pharmaceutical distribution agreement with CVS Health through 2032, reinforcing long-term revenue visibility. Revenue growth remains robust, climbing from $264.0B in 2022 to $359.1B in 2025, though net margins are thin at 1.12%.
McKesson presents a favorable risk-reward profile with 81% analyst buy ratings and a $956.43 consensus price target offering 2.8% upside. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. The company's strong cash flow generation ($6.1B operating cash flow in 2025) and strategic focus on oncology and specialty distribution support continued growth, though investors should monitor debt levels and competitive pressures in healthcare distribution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →